Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Blum HoldingsBLMH -4.76%14 Debt-to-EBITDA is -1.77 as of Sep. 2025. GuruFocus rates BLMH with a GF Score™ of 14/100 and a GF Value™ of $0.43 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 477 Healthcare Providers & Services companies, Blum Holdings ranks better than 79.87% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Blum Holdings's Debt-to-EBITDA or its related term are showing as below:
BLMH'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -12.61 Med: -0.53 Max: 0.57
Current: 0.57
During the past 13 years, the highest Debt-to-EBITDA Ratio of Blum Holdings was 0.57. The lowest was -12.61. And the median was -0.53.
BLMH's Debt-to-EBITDA is ranked better than 79.87% of 477
companies
in the Healthcare Providers & Services industry
Industry Median: 2.22
vs BLMH: 0.57
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Blum Holdings Debt-to-EBITDA Related Terms
Blum Holdings Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Blum Holdings's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BLMH vs HEWA, WGRX, PMHS: Debt-to-EBITDA Comparison
For the Pharmaceutical Retailers subindustry, Blum Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blum Holdings Debt-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Blum Holdings's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Blum Holdings's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Sep. 2025) EBITDA data.
Blum Holdings (BLMH) has a Debt-to-EBITDA of -1.77 as of Sep. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Blum Holdings. According to the industry distribution chart, Blum Holdings ranks #96 out of 477 companies in the Healthcare Providers & Services industry, placing it in the top 20.1%.
Is Blum Holdings' Debt-to-EBITDA too high?
Blum Holdings' current Debt-to-EBITDA is -1.77. Based on the distribution chart, Blum Holdings ranks #96 out of 477 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Blum Holdings has a GF Score™ of 14/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Blum Holdings' Debt-to-EBITDA compare to HEWA and WGRX?
According to the Healthcare Providers & Services industry distribution chart, Blum Holdings ranks #96 out of 477 companies for Debt-to-EBITDA. This places Blum Holdings in the top 20% of its industry — outperforming the majority of peers. The industry median Debt-to-EBITDA is 2.22. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Healthcare Providers & Services company?
The median Debt-to-EBITDA among Healthcare Providers & Services companies is 2.22, based on 477 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Blum Holdings. For the Healthcare Providers & Services industry, the median Debt-to-EBITDA is 2.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Blum Holdings's current Debt-to-EBITDA is -1.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blum Holdings stock overvalued right now?
Based on GuruFocus' analysis, Blum Holdings (BLMH) is currently considered Possible Value Trap. The stock's GF Value™ is $0.43, compared to a current price of $0.20 — trading 53.5% below its estimated fair value. The current Debt-to-EBITDA is -1.77. Blum Holdings' overall GF Score™ is 14/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Blum Holdings (BLMH), the current Debt-to-EBITDA is -1.77 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Blum Holdings (BLMH) Overvalued in 2026?
Based on GuruFocus' analysis, Blum Holdings stock appears to be undervalued.
The current stock price of $0.20 is trading 53.5% below its estimated GF Value™ of $0.43.
GuruFocus considers Blum Holdings to be Possible Value Trap.
Key valuation signals for BLMH:
Debt-to-EBITDA: -1.77
GF Value™: $0.43 vs. price of $0.20 (53.5% below fair value)
No single metric tells the full story. See the BLMH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Blum Holdings Inc is a cannabis company with operations in retail, production, distribution, and cultivation, with an emphasis on providing the highest quality of medical and adult-use cannabis products. It distributes its own branded products as well as third-party products to its retail dispensaries in California under the Korova brand. The company has two reportable segments; Cannabis Retail which generates key revenue and includes cannabis-focused retail, both physical stores and non-store front delivery, and Cannabis Distribution segment which includes cannabis distribution operations.
14GF Score
Get the complete analysis for BLMH
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BLMH has been successfully added to your 
